Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double-blind Placebo-controlled Randomized Parallel-group Clinical Study of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Subjects in Early Rehabilitation Period of Ischemic Stroke

NCT03815292 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT03815292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03815292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double-blind Placebo-controlled Randomized Parallel-group Clinical Study of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Subjects in Early Rehabilitation Period of Ischemic Stroke
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Completed
Start date
October 19, 2018
Completion date
January 27, 2020
Enrollment
276 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, mild cognitive impairment